Yun Peng

Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study

Yanhua Ding, Hong Wang, Cuiyun Li, 2021, Expert opinion on investigational drugs.

[Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].

R. Wu, Xin-yi Wu, Y. Zhen, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study

Sarah S Richtering, Y. Liu, M. Woodward, 2019, Journal of the American Heart Association.

Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects

Xiaojiao Li, Hong Zhang, Yanhua Ding, 2021, Expert opinion on investigational drugs.